Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Leukemia

  Free Subscription


Articles published in Hematol Oncol Clin North Am

Retrieve available abstracts of 14 articles:
HTML format



Single Articles


    October 2025
  1. HUANG J, Shadman M
    First-line Therapy: Time-Limited Venetoclax Doublet Therapy.
    Hematol Oncol Clin North Am. 2025;39:885-901.
    PubMed     Abstract available


  2. BROWN JR
    Resistance to Bruton Tyrosine Kinase Inhibitors.
    Hematol Oncol Clin North Am. 2025;39:951-963.
    PubMed     Abstract available


  3. THOMPSON PA, Parry EM
    Advances in the Understanding of Richter Transformation.
    Hematol Oncol Clin North Am. 2025;39:997-1012.
    PubMed     Abstract available


    July 2025
  4. VAINER N, Katsimigas A, Rotbain EC, Niemann CU, et al
    Understanding and Managing Infectious Complications in Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jul 25:S0889-8588(25)00065.
    PubMed     Abstract available


  5. SOUMERAI JD, Davids MS
    Triplet Therapies in Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jul 23:S0889-8588(25)00063.
    PubMed     Abstract available


  6. VOM STEIN AF, Frenzel LP
    Understanding and Targeting BCL2-inhibitor Resistance in Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jul 22:S0889-8588(25)00085.
    PubMed     Abstract available


  7. IATROU A, Agathangelidis A, Bordini J, Stamatopoulos K, et al
    Autonomous B-cell Receptor Signaling in Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jul 16:S0889-8588(25)00076.
    PubMed     Abstract available


  8. KAGERER A, Thompson MC
    Management of Relapsed and/or Refractory Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jul 16:S0889-8588(25)00080.
    PubMed     Abstract available


  9. BROWN JR, Davids MS
    The Rapidly Evolving Landscape of the Biology and Therapy of Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jul 16:S0889-8588(25)00086.
    PubMed    


  10. SWORDER B, Siddiqi T
    Immunotherapy in Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jul 8:S0889-8588(25)00082.
    PubMed     Abstract available


  11. BHAT SA, Woyach JA
    Frontline Treatment of Chronic Lymphocytic Leukemia with Continuous Bruton's Tyrosine Kinase Inhibitors: A Comprehensive Overview.
    Hematol Oncol Clin North Am. 2025 Jul 7:S0889-8588(25)00078.
    PubMed     Abstract available


  12. PEREZ-CASTRO A, Abruzzo LV, Oakes CC
    The Chronic Lymphocytic Leukemia Epigenome: A Powerful and Stable Framework for Understanding Biological and Clinical Heterogeneity.
    Hematol Oncol Clin North Am. 2025 Jul 7:S0889-8588(25)00077.
    PubMed     Abstract available


    June 2025
  13. VITALE C, Ferrario A, Zamprogna G, Coscia M, et al
    Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2025 Jun 30:S0889-8588(25)00064.
    PubMed     Abstract available


    August 2023
  14. SHAH P, Jacobson C
    Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia.
    Hematol Oncol Clin North Am. 2023 Aug 31:S0889-8588(23)00104.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.